ROYER R.; BUISSON J.-P., EUR. J. MED. CHEM.-CHIM. THER., 1980, 15, NO 3, 275-278
作者:ROYER R.、 BUISSON J.-P.
DOI:——
日期:——
METHODS FOR THE TREATMENT AND PREVENTION OF LIVER DISEASE
申请人:University of Pittsburgh - of the Commonwealth System of Higher Education
公开号:US20140249209A1
公开(公告)日:2014-09-04
The presently disclosed invention is directed to the discovery that hepatocyte nuclear factor 4 alpha (HNF4α; also known as NR2A1), a transcription factor, reverses hepatocyte dysfunction in an animal model of cirrhosis, resulting in improvement in hepatic function, treatment of cirrhosis, and prolonged survival.